← Back to Search

Virtual Reality Exposure Therapy for Specific Phobias

N/A
Waitlist Available
Led By Joseph F. McGuire, PhD
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 week after virtual reality exposure therapy session
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to use immersive virtual reality (VR) to help children and adolescents with specific phobias. VR allows them to face their fears in a simulated environment without leaving the clinician's office. This method could make treatment easier and more effective by providing realistic practice scenarios. VR has been used successfully for the treatment of various phobias and anxieties.

Eligible Conditions
  • Childhood Anxiety Disorder
  • Specific Phobias
  • Animal Phobia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 week after virtual reality exposure therapy session
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 week after virtual reality exposure therapy session for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Clinical Severity Rating (CSR) of Targeted Specific Phobia on Anxiety Disorder Interview Schedule for Children and Parents (ADIS-C/P)
Secondary study objectives
Screen for Childhood Anxiety and Related Disorders-Parent Report (SCARED-P)

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Virtual Reality Exposure TherapyExperimental Treatment1 Intervention
Participants will receive a single session of exposure therapy to address specific phobia that includes the use of virtual reality exposures.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Virtual Reality Exposure Therapy
2006
Completed Phase 3
~610

Find a Location

Who is running the clinical trial?

Johns Hopkins UniversityLead Sponsor
2,321 Previous Clinical Trials
14,873,938 Total Patients Enrolled
Joseph F. McGuire, PhDPrincipal InvestigatorJohns Hopkins University
1 Previous Clinical Trials
30 Total Patients Enrolled
~1 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top